ETR:SBS Stratec (SBS) Stock Price, News & Analysis → Did you know you can now trade Bitcoin in your regular brokerage account? (From DTI) (Ad) Free SBS Stock Alerts €40.15 +0.10 (+0.25%) (As of 04/19/2024 ET) Add Compare Share Share Today's Range€39.75▼€40.4550-Day Range€37.00▼€44.9552-Week Range€36.00▼€69.00Volume5,382 shsAverage Volume6,253 shsMarket Capitalization$488.22 millionP/E Ratio40.56Dividend Yield2.42%Price TargetN/A Stock AnalysisStock AnalysisChartHeadlinesStock AnalysisChartHeadlines Get Stratec alerts: Email Address Ad Paradigm PressForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISYou might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.Click here to find out that this 8,788% cryptocurrency is. About Stratec Stock (ETR:SBS)Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. The company operates through three segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment designs and manufactures automated analyzer systems, including service parts and consumables for clinical diagnostics and biotechnology customers. The Diatron segment offers systems, system components, consumables, and tests for the low throughput segment. The Smart Consumables segment develops and manufactures smart consumables in the fields of diagnostics, life sciences, and medical technologies. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.Read More SBS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SBS Stock News HeadlinesApril 16, 2024 | finance.yahoo.comShould Weakness in Stratec SE's (ETR:SBS) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?March 31, 2024 | finance.yahoo.comEarnings Miss: Stratec SE Missed EPS By 24% And Analysts Are Revising Their ForecastsApril 19, 2024 | DTI (Ad)Did you know you can now trade Bitcoin in your regular brokerage account?You see, thanks to one unique investor's brand new discovery - anyone with a regular brokerage account can now tap into the most explosive asset in history! That means you can skip the hassle of opening a Coinbase account… Bypass the fees and hard-to-remember passwords… Heck, you don’t even need a crypto wallet!March 29, 2024 | finance.yahoo.comStratec Full Year 2023 Earnings: Misses ExpectationsMarch 28, 2024 | markets.businessinsider.comEQS-News: STRATEC REPORTS RESULTS FOR 2023 FINANCIAL YEARMarch 28, 2024 | finance.yahoo.comStratec (ETR:SBS) Is Reducing Its Dividend To €0.55March 26, 2024 | finance.yahoo.comStratec (ETR:SBS) shareholders have endured a 62% loss from investing in the stock three years agoMarch 16, 2024 | morningstar.comStratec SE SBSApril 19, 2024 | Paradigm Press (Ad)Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISYou might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.March 2, 2024 | finance.yahoo.comWith 48% stake, Stratec SE (ETR:SBS) seems to have captured institutional investors' interestDecember 21, 2023 | markets.businessinsider.comEQS-News: STRATEC TO PARTICIPATE IN THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCENovember 21, 2023 | finance.yahoo.comStratec SE (ETR:SBS) Shares Could Be 35% Below Their Intrinsic Value EstimateNovember 7, 2023 | finance.yahoo.comDeclining Stock and Decent Financials: Is The Market Wrong About Stratec SE (ETR:SBS)?October 28, 2023 | markets.businessinsider.comEQS-News: STRATEC REPORTS RESULTS FOR FIRST NINE MONTHS OF 2023October 24, 2023 | finance.yahoo.comStratec's (ETR:SBS) Returns Have Hit A WallOctober 10, 2023 | finance.yahoo.comStratec (ETR:SBS) investors are sitting on a loss of 65% if they invested three years agoSeptember 24, 2023 | finance.yahoo.comWith 42% stake, Stratec SE (ETR:SBS) seems to have captured institutional investors' interestAugust 9, 2023 | markets.businessinsider.comEQS-News: STRATEC POSTS FINAL RESULTS FOR FIRST HALF OF 2023July 4, 2023 | uk.movies.yahoo.comSTRATEC COMPLETES ACQUISITION OF NATECH PLASTICSJune 14, 2023 | finance.yahoo.comIs Stratec SE (ETR:SBS) Trading At A 37% Discount?June 9, 2023 | msn.comHAUCK AUFHAEUSER INVESTMENT BANKING Maintains STRATEC SE (FWB:SBS) Buy RecommendationJune 8, 2023 | msn.comSRH ALSTERRESEARCH AG Maintains STRATEC SE (FWB:SBS) Hold RecommendationJune 7, 2023 | finance.yahoo.comSTRATEC SE: STRATEC Further Expands Its Presence in USA By Acquiring Natech PlasticsJune 7, 2023 | markets.businessinsider.comEQS-News: STRATEC SE: STRATEC FURTHER EXPANDS ITS PRESENCE IN USA BY ACQUIRING NATECH PLASTICSMay 31, 2023 | finance.yahoo.comWill Weakness in Stratec SE's (ETR:SBS) Stock Prove Temporary Given Strong Fundamentals?May 17, 2023 | markets.businessinsider.comEQS-News: STRATECS ANNUAL GENERAL MEETING APPROVES FURTHER DIVIDEND INCREASE: DISTRIBUTION RISES TO 0.97 PER SHAREMay 17, 2023 | finance.yahoo.comReturns On Capital At Stratec (ETR:SBS) Have Hit The BrakesSee More Headlines Receive SBS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Stratec and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeETR SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolETR:SBS CUSIPN/A CIKN/A Webwww.stratec.com Phone+49-7082-79160FaxN/AEmployees1,532Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)€0.99 Trailing P/E Ratio40.56 Forward P/E Ratio11.16 P/E Growth10.43Net Income$12.03 million Net Margins4.72% Pretax MarginN/A Return on Equity5.46% Return on Assets3.12% Debt Debt-to-Equity Ratio42.12 Current Ratio2.28 Quick Ratio1.65 Sales & Book Value Annual Sales$254.65 million Price / Sales1.92 Cash Flow€1.68 per share Price / Cash Flow23.85 Book Value€18.58 per share Price / Book2.16Miscellaneous Outstanding Shares12,160,000Free FloatN/AMarket Cap$488.22 million OptionableNot Optionable Beta0.14 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Marcus Wolfinger (Age 57)Chairman of Board of Management & CEO Comp: $1.13MDr. Robert Siegle (Age 57)Director of Finance & Human Resources and Member of Board of Management Comp: $914kDr. Claus Vielsack (Age 57)Director of Product Development & Member of Board of Management Comp: $710kMr. Hermann Leistner (Age 78)Founder & Advisor Dr. Georg Bauer (Age 51)Member of Management Board Mr. Jan KeppelerHead of Investor Relations, Sustainability & Corporate CommunicationsMr. Roland UtzHead of Supply Chain Management & Senior VPMore ExecutivesKey CompetitorsDrägerwerk AG & Co. KGaAETR:DRW3RHÖN-KLINIKUM AktiengesellschaftETR:RHKBiotest AktiengesellschaftETR:BIOCompuGroup Medical SE & Co. KGaAETR:COPShop Apotheke EuropeETR:SAEView All Competitors SBS Stock Analysis - Frequently Asked Questions How have SBS shares performed in 2024? Stratec's stock was trading at €45.55 at the beginning of the year. Since then, SBS stock has decreased by 11.9% and is now trading at €40.15. View the best growth stocks for 2024 here. Is Stratec a good dividend stock? Stratec (ETR:SBS) pays an annual dividend of €0.97 per share and currently has a dividend yield of 2.29%. The dividend payout ratio is 97.98%. Payout ratios above 75% are not desirable because they may not be sustainable. What other stocks do shareholders of Stratec own? Based on aggregate information from My MarketBeat watchlists, some companies that other Stratec investors own include Great Portland Estates (GPOR), Gogo (GOGO), Depomed (DEPO), Cenovus Energy (CVE), China Hydroelectric Corp Foreign (CHC), Bio-Rad Laboratories (BIO), Berkshire Hills Bancorp (BHLB), ASGN (ASGN), Apptio (APTI) and Anadarko Petroleum (APC). This page (ETR:SBS) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersBiden’s $374B Giveaway Into This SectorDTISHOCKING Crypto Leak…Crypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceOptions trading has suddenly become more reliable.Eagle PublishingHow Biden has already won 2024Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving TrendsUrgent alert: open this for a huge profit potentialTimothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Stratec SE Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.